Inflammasome activation in response to dead cells and their metabolites

Current Opinion in Immunology

Volumn 30, Issue , 2014, Pages 91-98

  Kono, Hajime ^a   Kimura, Yoshitaka ^a,b   Latz, Eicke ^c,d,e  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; CASPASE 11; CASPASE 3; CASPASE 6; CASPASE 7; CD14 ANTIGEN; CD36 ANTIGEN; CHOLESTEROL; CRYOPYRIN; FATTY ACID; GLUCOSE; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 1; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APOPTOSIS; ATHEROSCLEROSIS; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DIABETES MELLITUS; DNA FRAGMENTATION; ENZYME ACTIVATION; GOUT; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INSULIN RELEASE; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; METABOLITE; MOLECULAR PATHOLOGY; NECROPTOSIS; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; PYROPTOSIS; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE ACTIVATION; TUMOR LYSIS SYNDROME; URIC ACID BLOOD LEVEL; ANIMAL; IMMUNOLOGY;

ANIMALS; ATHEROSCLEROSIS; CELL DEATH; CHOLESTEROL, LDL; GOUT; HUMANS; INFLAMMASOMES; TUMOR LYSIS SYNDROME;

EID: 84907710652     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.09.001     Document Type: Review

References (116)

1. Spalding K.L., Bhardwaj R.D., Buchholz B.A., Druid H., Frisen J. Retrospective birth dating of cells in humans. Cell 2005, 122:133-143.
2. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15.
3. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009, 16:3-11.
4. Green D.R., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009, 9:353-363.
5. Rock K.L., Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008, 3:99-126.
6. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
7. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
8. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
9. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
10. Inohara N., Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003, 3:371-382.
11. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
12. Sancho D., Joffre O.P., Keller A.M., Rogers N.C., Martinez D., Hernanz-Falcon P., Rosewell I., Reis e Sousa C. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458:899-903.
13. Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13:114-119.
14. Ardoin S.P., Pisetsky D.S. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod Rheumatol 2008, 18:319-326.
15. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu Rev Immunol 2010, 28:321-342.
16. Kono H., Onda A., Yanagida T. Molecular determinants of sterile inflammation. Curr Opin Immunol 2014, 26:147-156.
17. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19:107-120.
18. Kilic M., Schäfer R., Hoppe J., Kagerhuber U. Formation of noncanonical high molecular weight caspase-3 and caspase-6 complexes and activation of caspase-12 during serum starvation induced apoptosis in AKR-2B mouse fibroblasts. Cell Death Differ 2002, 9:125-137.
19. Degterev A., Boyce M., Yuan J. A decade of caspases. Oncogene 2003, 22:8543-8567.
20. Lee S.H., Meng X.W., Flatten K.S., Loegering D.A., Kaufmann S.H. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death Differ 2013, 20:64-76.
21. Henry-Mowatt J., Dive C., Martinou J.C., James D. Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 2004, 23:2850-2860.
22. Zhang J.H., Xu M. DNA fragmentation in apoptosis. Cell Res 2000, 10:205-211.
23. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
24. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
25. Pan Q., Huang Y., Chen L., Gu J., Zhou X. SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC. Hum Cell 2014, 10.1007/s13577-014-0093-z.
26. Lau A., Wang S., Jiang J., Haig A., Pavlosky A., Linkermann A., Zhang Z.X., Jevnikar A.M. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg 2013, 13:2805-2818.
27. Miao E.A., Rajan J.V., Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011, 243:206-214.
28. Vigano E., Mortellaro A. Caspase-11: the driving factor for noncanonical inflammasomes. European J Immunol 2013, 43:2240-2245.
29. Bergsbaken T., Fink S.L., Cookson B.T. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009, 7:99-109.
30. Stienstra R., van Diepen J.A., Tack C.J., Zaki M.H., van de Veerdonk F.L., Perera D., Neale G.A., Hooiveld G.J., Hijmans A., Vroegrijk I., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 2011, 108:15324-15329.
31. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
32. Zheng F., Xing S., Gong Z., Mu W., Xing Q. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Mediators Inflamm 2014, 507208. 10.1155/2014/507208.
33. Cassel S.L., Joly S., Sutterwala F.S. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009, 21:194-198.
34. Broz P., Monack D.M. Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 2011, 243:174-190.
35. Bauernfeind F., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemr T., Wu J., Monks B.G., Fitzgerald K.A., et al. NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009, 183:787-791.
36. Keller M., Ruegg A., Werner S., Beer H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132:818-831.
37. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
38. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
39. Franchi L., Munoz-Planillo R., Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012, 13:325-332.
40. Fink S.L., Cookson B.T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 2006, 8:1812-1825.
41. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
42. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281.
43. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 2013, 496:238-242.
44. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521.
45. Kono H., Chen C.J., Ontiveros F., Rock K.L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010, 120:1939-1949.
46. Oda M., Satta Y., Takenaka O., Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002, 19:640-653.
47. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
48. Shimada M., Johnson R.J., May W.S., Lingegowda V., Sood P., Nakagawa T., Van Q.C., Dass B., Ejaz A.A. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant 2009, 24:2960-2964.
49. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009, 27:165-197.
50. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
51. Kellner-Weibel G., Jerome W.G., Small D.M., Warner G.J., Stoltenborg J.K., Kearney M.A., Corjay M.H., Phillips M.C., Rothblat G.H. Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler Thromb Vasc Biol 1998, 18:423-431.
52. Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
53. Miller Y.I., Worrall D.S., Funk C.D., Feramisco J.R., Witztum J.L. Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol Biol Cell 2003, 14:4196-4206.
54. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.
55. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011, 12:408-415.
56. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011, 17:179-188.
57. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140.
58. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., Becker C., Franchi L., Yoshihara E., Chen Z., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010, 11:897-904.
59. Rajamaki K., Lappalainen J., Oorni K., Valimaki E., Matikainen S., Kovanen P.T., Eklund K.K. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 2010, 5:e11765.
60. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., Asano M., Moriwaki H., Seishima M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:656-660.
61. Menu P., Pellegrin M., Aubert J.F., Bouzourene K., Tardivel A., Mazzolai L., Tschopp J. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis 2011, 2:e137.
62. Hendrikx T., Bieghs V., Walenbergh S.M., van Gorp P.J., Verheyen F., Jeurissen M.L., Steinbusch M.M., Vaes N., Binder C.J., Koek G.H., et al. Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice. PLoS ONE 2013, 8:e78792.
63. Sheedy F.J., Grebe A., Rayner K.J., Kalantari P., Ramkhelawon B., Carpenter S.B., Becker C.E., Ediriweera H.N., Mullick A.E., Golenbock D.T., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 2013, 14:812-820.
64. Cyrus T., Witztum J.L., Rader D.J., Tangirala R., Fazio S., Linton M.F., Funk C.D. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999, 103:1597-1604.
65. Cyrus T., Pratico D., Zhao L., Witztum J.L., Rader D.J., Rokach J., FitzGerald G.A., Funk C.D. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 2001, 103:2277-2282.
66. George J., Afek A., Shaish A., Levkovitz H., Bloom N., Cyrus T., Zhao L., Funk C.D., Sigal E., Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 2001, 104:1646-1650.
67. Choi S.H., Harkewicz R., Lee J.H., Boullier A., Almazan F., Li A.C., Witztum J.L., Bae Y.S., Miller Y.I. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009, 104:1355-1363.
68. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H.I., Spinas G.A., Kaiser N., Halban P.A., Donath M.Y. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002, 110:851-860.
69. Jourdan T., Godlewski G., Cinar R., Bertola A., Szanda G., Liu J., Tam J., Han T., Mukhopadhyay B., Skarulis M.C., et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 2013, 19:1132-1140.
70. Welsh N., Cnop M., Kharroubi I., Bugliani M., Lupi R., Marchetti P., Eizirik D.L. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?. Diabetes 2005, 54:3238-3244.
71. Lecube A., Pachon G., Petriz J., Hernandez C., Simo R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS ONE 2011, 6:e23366.
72. Chen K., Zhang J., Zhang W., Zhang J., Yang J., Li K., He Y. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy. Int J Biochem Cell Biol 2013, 45:932-943.
73. Westwell-Roper C., Dai D.L., Soukhatcheva G., Potter K.J., van Rooijen N., Ehses J.A., Verchere C.B. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011, 187:2755-2765.
74. Westwell-Roper C.Y., Ehses J.A., Verchere C.B. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1beta production and beta-cell dysfunction. Diabetes 2014, 63:1698-1711.
75. Li S., Du L., Zhang L., Hu Y., Xia W., Wu J., Zhu J., Chen L., Zhu F., Li C., Cathepsin B., et al. contributes to autophagy-related 7 (Atg7)-induced nod-like receptor 3 (NLRP3)-dependent proinflammatory response and aggravates lipotoxicity in rat insulinoma cell line. J Biol Chem 2013, 288:30094-30104.
76. Liu-Bryan R., Scott P., Sydlaske A., Rose D.M., Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheumatol 2005, 52:2936-2946.
77. Liu-Bryan R., Pritzker K., Firestein G.S., Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005, 174:5016-5023.
78. Scott P., Ma H., Viriyakosol S., Terkeltaub R., Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006, 177:6370-6378.
79. Ng G., Sharma K., Ward S.M., Desrosiers M.D., Stephens L.A., Schoel W.M., Li T., Lowell C.A., Ling C.C., Amrein M.W., et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008, 29:807-818.
80. Abbott R.D., Brand F.N., Kannel W.B., Castelli W.P. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988, 41:237-242.
81. Krishnan E., Svendsen K., Neaton J.D., Grandits G., Kuller L.H., Group M.R. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168:1104-1110.
82. Liu L., Chan C. IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer's disease. Neurobiol Aging 2014, 35:309-321.
83. Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., Yagi N., Ohto U., Kimoto M., Miyake K., et al. Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab 2012, 15:518-533.
84. Reynolds C.M., McGillicuddy F.C., Harford K.A., Finucane O.M., Mills K.H., Roche H.M. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol Nutr Food Res 2012, 56:1212-1222.
85. Alvarez-Garcia O., Rogers N.H., Smith R.G., Lotz M.K. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1. Arthritis Rheumatol 2014, 66:1779-1788.
86. Frommer K.W., Schaffler A., Rehart S., Lehr A., Muller-Ladner U., Neumann E. Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann Rheum Dis 2013, 10.1136/annrheumdis-2013-203755.
87. Jang H.J., Kim H.S., Hwang D.H., Quon M.J., Kim J.A. Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin. Am J Physiol Endocrinol Metab 2013, 304:E1077-E1088.
88. Luo X., Yang Y., Shen T., Tang X., Xiao Y., Zou T., Xia M., Ling W. Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells. Nutr Metab (Lond) 2012, 9:34.
89. Freigang S., Ampenberger F., Weiss A., Kanneganti T.D., Iwakura Y., Hersberger M., Kopf M. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis. Nat Immunol 2013, 14:1045-1053.
90. Grassme H., Carpinteiro A., Edwards M.J., Gulbins E., Becker K.A. Regulation of the inflammasome by ceramide in cystic fibrosis lungs. Cell Physiol Biochem 2014, 34:45-55.
91. von Bismarck P., Wistadt C.F., Klemm K., Winoto-Morbach S., Uhlig U., Schutze S., Adam D., Lachmann B., Uhlig S., Krause M.F. Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. Am J Respir Crit Care Med 2008, 177:1233-1241.
92. Jia S.J., Jin S., Zhang F., Yi F., Dewey W.L., Li P.L. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am J Physiol Heart Circ Physiol 2008, 295:H1743-H1752.
93. Mishra B.B., Rathinam V.A., Martens G.W., Martinot A.J., Kornfeld H., Fitzgerald K.A., Sassetti C.M. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta. Nat Immunol 2013, 14:52-60.
94. Hernandez-Cuellar E., Tsuchiya K., Hara H., Fang R., Sakai S., Kawamura I., Akira S., Mitsuyama M. Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol 2012, 189:5113-5117.
95. Lin S.H., Maiese K. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J Cereb Blood Flow Metab 2011, 21:262-275.
96. Kim Y.M., Talanian R.V., Li J., Billiar T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J Immunol 1998, 161:4122-4128.
97. Park Y.J., Yoon S.J., Suh H.W., Kim D.O., Park J.R., Jung H., Kim T.D., Yoon S.R., Min J.K., Na H.J., et al. TXNIP deficiency exacerbates endotoxic shock via the induction of excessive nitric oxide synthesis. PLoS Pathog 2013, 9:e1003646.
98. Mao K., Chen S., Chen M., Ma Y., Wang Y., Huang B., He Z., Zeng Y., Hu Y., Sun S., et al. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res 2013, 23:201-212.
99. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916.
100. Boileau C., Martel-Pelletier J., Moldovan F., Jouzeau J.Y., Netter P., Manning P.T., Pelletier J.P. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arthritis Rheumatol 2002, 46:2637-2647.
101. Furlan R., Kurne A., Bergami A., Brambilla E., Maucci R., Gasparini L., Butti E., Comi G., Ongini E., Martino G. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 150:10-19.
102. Gattu A.K., Birkenfeld A.L., Iwakiri Y., Jay S., Saltzman M., Doll J., Protiva P., Samuel V.T., Crawford S.E., Chung C. Pigment epithelium-derived factor (PEDF) suppresses IL-1beta-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling. Endocrinology 2014, 155:1373-1385.
103. Rubic T., Lametschwandtner G., Jost S., Hinteregger S., Kund J., Carballido-Perrig N., Schwarzler C., Junt T., Voshol H., Meingassner J.G., et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 2008, 9:1261-1269.
104. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
105. Miao H., Ou J., Ma Y., Guo F., Yang Z., Wiggins M., Liu C., Song W., Han X., Wang M., et al. Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice. Cell Rep 2014, 7:223-235.
106. Fukumoto J., Fukumoto I., Parthasarathy P.T., Cox R., Huynh B., Ramanathan G.K., Venugopal R.B., Allen-Gipson D.S., Lockey R.F., Kolliputi N. NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am J Physiol Cell Physiol 2013, 305:C182-C189.
107. Xu J.F., Washko G.R., Nakahira K., Hatabu H., Patel A.S., Fernandez I.E., Nishino M., Okajima Y., Yamashiro T., Ross J.C., et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med 2012, 185:547-556.
108. Henriksbo B.D., Lau T.C., Cavallari J.F., Denou E., Chi W., Lally J.S., Crane J.D., Duggan B.M., Foley K.P., Fullerton M.D., et al. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance. Diabetes 2014, 10.2337/db13-1398.
109. Mandey S.H., Kuijk L.M., Frenkel J., Waterham H.R. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheumatol 2006, 54:3690-3695.
110. Pontillo A., Paoluzzi E., Crovella S. The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. Eur J Hum Genet 2010, 18:844-847.
111. Montero M.T., Matilla J., Gomez-Mampaso E., Lasuncion M.A. Geranylgeraniol regulates negatively caspase-1 autoprocessing: implication in the Th1 response against Mycobacterium tuberculosis. J Immunol 2004, 173:4936-4944.
112. Maeda A., Yano T., Itoh Y., Kakumori M., Kubota T., Egashira N., Oishi R. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells. Atherosclerosis 2010, 208:112-118.
113. Tanaka S., Sakamoto K., Yamamoto M., Mizuno A., Ono T., Waguri S., Kimura J. Mechanism of statin-induced contractile dysfunction in rat cultured skeletal myofibers. J Pharmacol Sci 2010, 114:454-463.
114. Shi J., Zhao Y., Wang Y., Gao W., Ding J., Li P., Hu L., Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014, 10.1038/nature13683.
115. Klinkner A.M., Waites C.R., Kerns W.D., Bugelski P.J. Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy. J Histochem Cytochem 1995, 43:1071-1078.
116. Vetere A., Choudhary A., Burns S.M., Wagner B.K. Targeting the pancreatic beta-cell to treat diabetes. Nat Rev Drug Discov 2014, 13:278-289. 10.1038/nrd4231.